抗體的生物素化標(biāo)記實驗要點：

1. 磷脂酰肌醇激酶抗體費用 如在反應(yīng)混合液中有疊氮鈉或游離氨基存在,會抑制標(biāo)記反應(yīng)。因此,蛋白質(zhì)在反應(yīng)前要對 0.1mol/L碳酸氫鈉緩沖液或0.5mol/L硼酸緩沖液充分透析；

2.所用的NHSB及待生物素化蛋白質(zhì)之間的分子比按蛋白質(zhì)表面的ε-氨基的密度會有所不同,選擇不當(dāng)則影響標(biāo)記的效率,應(yīng)先用幾個不同的分子比來篩選最適條件；

3.用NHSB量過量也是不利的,抗原的結(jié)合位點可能因此被封閉,導(dǎo)致抗體失活；

4.由于抗體的氨基不易接近可能造成生物素化不足,此時可加入去污劑如 Triton x-100, Tween20等；

5.當(dāng)游離ε-氨基(賴氨酸殘基的氨基)存在于抗體的抗原結(jié)合位點時,或位于酶的催化位點時,生物素化會降低或損傷抗體蛋白的結(jié)合力或活性；

6.生物素還可能與不同的功能基團,如羰基、氨基、巰基、異咪唑基及苯酚基,也可與糖基共價結(jié)合；

7.交聯(lián)反應(yīng)后,應(yīng)充分透析,否則,殘余的生物素會對生物素化抗體與親和素的結(jié)合產(chǎn)生競爭作用；

8.在細(xì)胞的熒光標(biāo)記實驗中,中和親和素的本底低,但由于鏈霉親和素含有少量正電荷,故對某些細(xì)胞可導(dǎo)致高本底。

產(chǎn)品訂購信息：
英文名稱  Anti-PI3K/PI3 kinase p85 alpha subunit 

中文名稱   磷脂酰肌醇激酶抗體費用 

別    名  GRB1; p50 alpha; p55 alpha; p85 alpha; p85; Phosphatidylinositol 3 kinase associated p85 alpha; Phosphatidylinositol 3 kinase regulatory 1; Phosphatidylinositol 3 kinase regulatory alpha subunit; Phosphoinositide 3 kinase regulatory subunit polypeptide 1 (p85 alpha); PI3 kinase p85 alpha subunit; PI3 kinase p85 subunit alpha; PI3K ; PIK3R1; PtdIns 3 kinase p85 alpha; SH3_PI3K_p85alpha; P85A_HUMAN.

濃    度   1mg/1ml

規(guī) 格  0.1ml/100μg 0.2ml/200μg

抗體來源   Rabbit

克隆類型   polyclonal

交叉反應(yīng)   Human, Mouse, Rat, Chicken, Dog, Cow, Horse 

產(chǎn)品類型   一抗  

研究領(lǐng)域     細(xì)胞生物 免疫學(xué) 神經(jīng)生物學(xué) 信號轉(zhuǎn)導(dǎo) 細(xì)胞凋亡 激酶和磷酸酶

蛋白分子量  predicted molecular weight: 80kDa

性    狀   Lyophilized or Liquid

免 疫 原 KLH conjugated synthetic peptide derived from human PI3 kinase p85 subunit alpha (560-710aa) 

亞    型   IgG

純化方法   affinity purified by Protein A

儲 存 液   0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide

磷脂酰肌醇激酶抗體費用 產(chǎn)品應(yīng)用    WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

（石蠟切片需做抗原修復(fù)） 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存條件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

產(chǎn)品介紹 The enzyme phosphatidylinositol 3 kinase (PI3 kinase) is a lipid kinase that generates phosphatidylinositol 3, 4, 5-triphosphate in response to receptor activation in many signal transduction pathways. Class IA PI3Ks exist as a heterodimer of a catalytic 110 kDa (p110) and a regulatory p85 subunit (e.g. p85 alpha). p85 alpha is an adaptor molecule that regulates the activity of the catalytic p110 subunit by binding to phosphorylated receptor tyrosine kinases (RTKs) through its SH2 domain and mediating the interaction between p110 and the plasma membrane. p85 alpha is necessary for insulin-stimulated increase in glucose uptake and glycogen synthesis in insulin-sensitive tissues.

Function : Binds to activated (phosphorylated) protein-Tyr kinases, through its SH2 domain, and acts as an adapter, mediating the association of the p110 catalytic unit to the plasma membrane. Necessary for the insulin-stimulated increase in glucose uptake and glycogen synthesis in insulin-sensitive tissues.

Subunit : Heterodimer of a regulatory subunit PIK3R1 and a p110 catalytic subunit (PIK3CA, PIK3CB or PIK3CD). Interacts with FER. Interacts (via SH2 domain) with TEK/TIE2 (tyrosine phosphorylated). Interacts with PTK2/FAK1 (By similarity). Interacts with phosphorylated TOM1L1. Interacts with phosphorylated LIME1 upon TCR and/or BCR activation. Interacts with SOCS7. Interacts with RUFY3. Interacts (via SH2 domain) with CSF1R (tyrosine phosphorylated). Interacts with LYN (via SH3 domain); this enhances enzyme activity. Interacts with phosphorylated LAT, LAX1 and TRAT1 upon TCR activation. Interacts with CBLB. Interacts with HIV-1 Nef to activate the Nef associated p21-activated kinase (PAK). This interaction depends on the C-terminus of both proteins and leads to increased production of HIV. Interacts with HCV NS5A. The SH2 domains interact with the YTHM motif of phosphorylated INSR in vitro. Also interacts with tyrosine-phosphorylated IGF1R in vitro. Interacts with CD28 and CD3Z upon T-cell activation. Interacts with IRS1 and phosphorylated IRS4, as well as with NISCH and HCST. Interacts with FASLG, KIT and BCR. Interacts with AXL, FGFR1, FGFR2, FGFR3 and FGFR4 (phosphorylated). Interacts with FGR and HCK. Interacts with PDGFRA (tyrosine phosphorylated) and PDGFRB (tyrosine phosphorylated). Interacts with ERBB4 (phosphorylated). Interacts with NTRK1 (phosphorylated upon ligand-binding).

Tissue Specificity : Isoform 2 is expressed in skeletal muscle and brain, and at lower levels in kidney and cardiac muscle. Isoform 2 and isoform 4 are present in skeletal muscle (at protein level).

Phosphorylated. Tyrosine phosphorylated in response to signaling by FGFR1, FGFR2, FGFR3 and FGFR4. Phosphorylated by CSF1R. Phosphorylated by ERBB4. Phosphorylated on tyrosine residues by TEK/TIE2. Dephosphorylated by PTPRJ. Phosphorylated by PIK3CA at Ser-608; phosphorylation is stimulated by insulin and PDGF. The relevance of phosphorylation by PIK3CA is however unclear. Phosphorylated in response to KIT and KITLG/SCF. Phosphorylated by FGR.

Similarity : Belongs to the PI3K p85 subunit family.

Contains 1 Rho-GAP domain.

Contains 2 SH2 domains.

Contains 1 SH3 domain.

Database links : UniProtKB/Swiss-Prot: P27986.2

Entrez Gene: 5295 Human

Entrez Gene: 18708 Mouse

Entrez Gene: 25513 Rat

Omim: 171833 Human

SwissProt: P27986 Human

SwissProt: P26450 Mouse

SwissProt: Q63787 Rat

Unigene: 132225 Human

激酶和磷酸酶（Kinases and Phosphatases）

抗體的鑒定：

1）磷脂酰肌醇激酶抗體費用 抗體的效價鑒定：不管是用于診斷還是用于,制備抗體的目的都是要求較高效價。不同的抗原制備的抗體,要求的效價不一。鑒定效價的方法很多,包括有試管凝集反應(yīng),瓊脂擴散試驗,酶聯(lián)免疫吸附試驗等。常用的抗原所制備的抗體一般都有約成的鑒定效價的方法,以資比較。如制備抗抗體的效價,一般就采用瓊脂擴散試驗來鑒定。

2）抗體的特異性鑒定：抗體的特異性是指與相應(yīng)抗原或近似抗原物質(zhì)的識別能力。抗體的特異性高,它的識別能力就強。衡量特異性通常以交叉反應(yīng)率來表示。交叉反應(yīng)率可用競爭抑制試驗測定。以不同濃度抗原和近似抗原分別做競爭抑制曲線,計算各自的結(jié)合率,求出各自在IC50時的濃度,并按公式計算交叉反應(yīng)率。 

如果所用抗原濃度IC50濃度為pg/管,而一些近似抗原物質(zhì)的IC50濃度幾乎是無窮大時,表示這一抗血清與其他抗原物質(zhì)的交叉反應(yīng)率近似為0,即該血清的特異性較好。

3）抗體親和力：是指抗體和抗原結(jié)合的牢固程度。親和力的高低是由抗原分子的大小,抗體分子的結(jié)合位點與抗原決定簇之間立體構(gòu)型的合適度決定的。有助于維持抗原抗體復(fù)合物穩(wěn)定的分子間力有氫鍵,疏水鍵,側(cè)鏈相反電荷基因的庫侖力,范德華力和空間斥力。親和力常以親和常數(shù)K表示,K的單位是L/mol。抗體親和力的測定對抗體的篩選,確定抗體的用途,驗證抗體的均一性等均有重要意義。

Anti-A Raf/ARAF/FITC 熒光素標(biāo)記A-Raf抗體IgGMulti-class antibodies規(guī)格： 0.2ml

Anti-KLK14/FITC 熒光素標(biāo)記激肽釋放酶14抗體IgGMulti-class antibodies規(guī)格： 0.2ml

Rhesus antibody Rh CCDC160 卷曲螺旋結(jié)構(gòu)域蛋白160抗體 規(guī)格 0.2ml

A/H1N1-M2 Human(Avian influenza Matrix Protein-2 Human) A型人病毒H1N1-M2蛋白多肽 0.5mg

HYPE 英文名稱： 舞蹈癥蛋白相互作用蛋白13抗體 0.2ml

Rhesus antibody Rh SMAD9 SMAD家族9抗體 規(guī)格 0.2ml

Anti-KLK14/FITC 熒光素標(biāo)記激肽釋放酶14抗體IgGMulti-class antibodies規(guī)格： 0.2ml

PPP1R1A(Human protein phosphatase 1 regulatory subunit A) ELISA Kit 人蛋酸酶1調(diào)控/抑制因子亞基1AMulti-class antibodies規(guī)格： 48T

Anti-phosphos-PCNA (Tyr211) 磷酸化增殖細(xì)胞核抗原抗體Multi-class antibodies規(guī)格： 0.1ml

Rhesus antibody Rh HMW Kininogen 高分子量激肽原重鏈抗體 規(guī)格 0.2ml

ARA(Human anti-gastric parietal cell antibody) ELISA Kit 人抗網(wǎng)硬蛋白抗體 96T

PGGT1B 英文名稱： 香葉烯基轉(zhuǎn)移酶1β抗體 0.2ml

CRISP3 英文名稱： 富含半胱酸分泌蛋白3抗體 0.2ml

Anti-phosphos-PCNA (Tyr211) 磷酸化增殖細(xì)胞核抗原抗體Multi-class antibodies規(guī)格： 0.1ml

SmIg(Human Surface Membrane Immunoglobulin) ELISA Kit 人細(xì)胞膜表面免疫球蛋白Multi-class antibodies規(guī)格： 48T

Anti-PTN 多效生長因子抗體Multi-class antibodies規(guī)格： 0.2ml

Rhesus antibody Rh HB EGF/DTSF 肝素結(jié)合性表皮生長因子抗體 規(guī)格 0.1ml

Cyclin-D1 ELISA Kit 大鼠細(xì)胞周期素D1 96T

Phospho-p73(Tyr99) 英文名稱： 磷酸化P73抑制基因抗體 0.1ml

Bcl-10 英文名稱： Bcl-10抗體 0.1ml

Anti-PTN 多效生長因子抗體Multi-class antibodies規(guī)格： 0.2ml

CL-0210SiHa(人子宮頸鱗癌細(xì)胞)5×106cells/瓶×2

REG4 Others Human 人 REG4 / RELP / GISP CHO細(xì)胞裂解液 (陽性對照)

人真皮平滑肌細(xì)胞cDNAHDLEC cDNA

豬腎細(xì)胞;PK-15 子宮內(nèi)膜腺癌細(xì)胞，HEC-1-B細(xì)胞 Fc細(xì)胞，615小鼠前瘤株

人胚腎細(xì)胞;293FT

HA Others H1N1 甲型 H1N1 (A/WSN/1933) 血凝素 (Hemagglutinin / HA) 人細(xì)胞裂解液 (陽性對照)

CL-0208SH-SY5Y(人神經(jīng)母細(xì)胞瘤細(xì)胞)5×106cells/瓶×2

RAC1 Others Human 人 RAC1 / MIG5 桿狀病毒-昆蟲細(xì)胞裂解液 (陽性對照)

人小膠質(zhì)細(xì)胞cDNAHM cDNA

A549細(xì)胞，人 人低分化,SK-LU-1細(xì)胞 平滑肌細(xì)胞Many types of cells包裝：5 × 105次方(1ml)

犬腎細(xì)胞;MDCK(NBL-2)

PLAT Others Human 人 tPAβ 人細(xì)胞裂解液 (陽性對照)

磷脂酰肌醇激酶抗體費用 CPLX3 Others Human 人 CPLX3 / Complexin 3 人細(xì)胞裂解液 (陽性對照)

CM-H069人膀胱平滑肌細(xì)胞完全培養(yǎng)基100mL

人表皮黑色素細(xì)胞-深色素HEM-d

Hs 683細(xì)胞，人腦視神經(jīng)細(xì)胞 人癌細(xì)胞,MDA-MB-468細(xì)胞 動物上皮細(xì)胞培養(yǎng)基EpiCM-a

大額牛肺細(xì)胞;BFR-L1

LXN Others Human 人 Latexin / LXN / TCI 人細(xì)胞裂解液 (陽性對照)